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INTODUCTION:  Ileal  conduit  stomal  stenosis  is a  difﬁcult  complication  to manage.  Deﬁnitive  treatment
usually  requires  refashioning  or a reconstruction  of  the  conduit.  There  remains  a need  for  minimally
invasive  procedures  that  can  restore  function  to the stoma  while  avoiding  the  risks  associated  with  a
signiﬁcant  surgical  procedure.  This  case  illustrates  a novel  approach  to the  management  of this  compli-
cation.
PRESENTATION  OF  CASE:  An  84  year  old female  with  muscle-invasive  bladder  cancer  underwent  cys-
tectomy  with  formation  of  an  ileal  conduit  urinary  diversion  system.  Her  recovery  was  complicated
by  stomal  stenosis  leading  to recurrent  urinary  tract  infections.  The  Memokath  Stent  045  is a thermo-
expandable  nickel–titanium  stent  designed  for treatment  of  urethral  strictures.  The  stent was  inserted
into  the stoma  under  direct  vision  without  the need  for general  anaesthesia  or intraoperative  radiogra-
phy.  The  conduit  remains  patent  12 months  after  insertion  and  the  metal  stent  showed  no  evidence  of
migration,  calciﬁcation,  oxidation  or degradation.
DISCUSSION:  The  use  of  a thermo-expandable  nickel–titanium  stent  is able  to  provide  the  patency  required
to  treat  ileal  conduit  stomal  stenosis.  In this  case,  insertion  of  the  stent  was a simple  procedure  and
no  adverse  events  or degradation  of  the  stent  was  identiﬁed  at 12 months  after  insertion.  The  need
for  a signiﬁcant  surgical  procedure  such  as  a refashioning  or  reconstruction  was  avoided  and  general
anaesthesia  was  not  required  to perform  the  procedure.
CONCLUSION:  This  case  report  highlights  the  possibility  of  using  the  thermo-expandable  Memokath  Stent
045 as  an alternative  to the  long-term  management  of  ileal conduit  stomal  stenosis.
Publi
he CC©  2015  The  Authors.  
access  article  under  t
. Introduction
The ileal conduit urinary diversion system is commonly formed
ollowing radical cystectomy. It is regarded as the safest and sim-
lest form of urinary diversion and it is the gold standard for which
ll other urinary diversion systems are compared against [1]. Com-
lications associated with ileal conduit urinary diversion include
hose affecting the bowel, stoma, conduit and the uretero-intestinal
nastomosis. The major consequences with any of the compli-
ations are injury to renal tissue compromising its function and
reakdown of all or part of the urinary diversion system. Stomal
tenosis is one such complication which can lead to secondary
omplications such as obstruction, infection and renal injury.
Ileal conduit stomal stenosis is a complication which is difﬁcult
o manage for both patients and doctors. The management options
vailable include conservative approaches such as catheterisation
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and mechanical dilation while deﬁnitive management involves
refashioning the stoma or a reconstruction of the conduit [1].
Current minimally invasive approaches such as dilation are lim-
ited to cases where the site of stenosis is close to the level of the skin
but often still require surgical intervention [2]. The authors present
this unique case which illustrate the potential for an innovative,
minimally invasive approach to the management of stomal stenosis
utilising a nickel–titanium thermo-expandable urethral Memokath
Stent 045 to maintain patency.
2. Presentation of case
An 84 year old female presented with haematuria and lower
urinary tract symptoms to our institution in 2013. She has no signif-
icant relevant medical history. She was subsequently managed and
treated with a transurethral resection of bladder tumour, the histo-
logical results of the resection lead to a diagnosis of muscle-invasive
nodular and papillary transitional cell carcinoma.
The patient underwent a cystectomy, urethrectomy, hysterec-
tomy and bilateral salpingo-oophorectomy with pelvic lymph node
dissection with formation of an ileal conduit. A Bricker end-to-side
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. An intraoperative image showing the metal Memokath 045 ureteric stent in
the  stomal oriﬁce with 10 cm of a 5 French catheter inserted through the lumen to
demonstrate patency.
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fig. 2. Abdominal radiograph of the patient three months after stent insertion. The
0 mm metal stent is observed without any signs of migration. Clinically, the ileal
onduit is functioning well with no signs of irritation or degradation.
nastomosis was performed with the ileal conduit measuring 26 cm
n length and ureteric were stents placed bilaterally. There were no
igniﬁcant intraoperative complications.Within the ﬁrst 24 h following the operation, the external aspect
f the stoma became dark red and black colour in colour. Over the
ext week, necrotic tissue was evident on the external mucosal sur-
ace however there were no signs of infection. During the secondPEN  ACCESS
f Surgery Case Reports 19 (2016) 124–126 125
week, the base of the stoma began to regain a pink colour and was
normal by the end of this week. A retrograde ileal conduitogram
was attempted on day 16 but insertion of the catheter was unsuc-
cessful due to suspected conduit stenosis. A repeat study was
performed through the ureteric stents on day 19 which revealed a
patent conduit and the ureteric stents were removed. Over the next
week the rate of drainage from the stoma gradually declined. On
day 26, the stoma had a 16 French Foley catheter inserted to achieve
adequate drainage. On day 40 the size of the catheter was reduced
to a 14 French due to difﬁculties with catheter insertion. Over the
next ﬁve months, the conduit remained dependent on catheterisa-
tion for sufﬁcient drainage. A conduitoscopy with stomal dilation
using Hegar dilators was performed which conﬁrmed a 45 mm seg-
ment of stenosis below the level of the skin, involving the level of
the abdominal muscles.
Within these ﬁrst 6 months the patient’s recovery was  also
complicated by ﬁve urinary tract infections. As a result of the
complications and increasingly difﬁcult catheter changes, a 70 mm
Memokath Stent 045 was inserted at seven months after the orig-
inal procedure. Insertion of the stent was  performed under IV
sedation without the need for intraoperative radiography. Follow-
ing insertion of the stent, the patient recovered well and has not
required any further catheterisation. The patient commented that
she is highly satisﬁed with the current result and has not experi-
enced any pain or discomfort associated with the stent. The patient
was reviewed at 3 and 12 months after insertion of the stent and
during both assessments, there was  no evidence of stent migra-
tion, calciﬁcation, oxidation or luminal obstruction and the stoma
was fully functional. Abdominal radiography conﬁrmed the stent
was not deformed and there are no signs of any calciﬁcation on the
inner aspect of the stent. This work has been reported in line with
the CARE criteria [3].
3. Discussion
The ileal conduit is regarded as the standard urinary diversion
system utilised in patients following cystectomy for bladder cancer
[1]. A signiﬁcant proportion of patients undergoing this procedure
are elderly and studies have reported that the mean age of patients
undergoing this procedure is approximately 60 years [4,5]. A grad-
ual decline in health and functional status following the procedure
often occurs [6,7]. As a result of advancing age, comorbidities and
deconditioning, patients who  develop complications related to the
ileal conduit may  not always be suitable for surgical intervention
as the risks may  outweigh the beneﬁts. The introduction of new
minimally invasive procedures that can achieve adequate patency
of the conduit and stoma would be of beneﬁt for many patients.
Ileal conduit stomal stenosis classically presents as a late com-
plication with an insidious onset. The rate of this complication has
been reported to be 0.7–8.5% and this variation is thought to be due
to differences in technical skill levels of surgeons performing the
procedure [2,8,9]. It is believed that chronic ischemia of the conduit
may  be a major contributing factor to the development of stenosis
[10]. The risk of stenosis can be minimised during the formation of
the ileal conduit with appropriate selection and handling of the
isolated bowel segment [1,10]. Other risk factors include fascial
constriction, retraction and local skin changes such as hyperkerato-
sis resulting from urine causing chronic irritation. Adequate care of
the stoma is necessary to minimise the risk of stomal stenosis [1,2].
Considering the clinical course of the case presented by the authors
it is highly likely that the primary causative factor was ischemia.The Memokath Stent 045 is a thermo-expandable
nickel–titanium stent designed for the long-term treatment
of urethral strictures [11]. The authors believed that the size of
this stent in conjunction with the thermo-expandable property
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cig. 3. Image of the stoma three months following stent insertion. The stoma was
unctioning normally and draining through the stent adequately.
ade it a candidate for use in the treatment of ileal conduit stomal
tenosis. In the presented case, the stent was inserted into the
toma under direct vision without the need for intraoperative
adiography (Fig. 1). Stent insertion was quick and did not require
 general anaesthetic, making it a more suitable treatment option
or elderly and frail patients compared to a refashioning or recon-
truction. The limitations of this approach is the possibility of
tent migration, encrustation, oxidation and pressure necrosis.
hese potential issues arise from the constant exposure to urine
nd air when placed in the stoma [12]. These issues can be rapidly
esolved due to the ease of removing the stent but ongoing review
nd monitoring remains important to detect complications early.
he stent removal process involves exposing the stent to cold
ater which allows it to expand and uncoil, a procedure that can
e performed under local anaesthetic.
The patient was reviewed at 3 and 12 months after insertion of
he stent. On examination at both reviews, the stent was  appropri-
tely positioned with no signs of deterioration (Fig. 2). The stoma
as fully patent with excellent urinary drainage and the patient has
ot required the use of catheters to facilitate drainage (Fig. 3). The
atient commented that the stent does not impose any restrictions
n her level of physical activity and was satisﬁed with the outcome.
With the presentation of this case report, the authors illustrated
he application of a minimally invasive procedure which utilised a
etal stent to treat ileal conduit stomal stenosis. The key learn-
ng points from this case is demonstrated by the approach having
he advantage of not requiring a general anaesthetic and adequate
atency can be achieved without a major surgical procedure, mak-
ng it a suitable alternative for elderly or frail patients. The ease of
eversibility of the procedure proves reassuring but ongoing mon-
toring is important in all cases.
. Conclusion
There remains a need for minimally invasive options to use in
he treatment of ileal conduit stomal stenosis. This case report high-
ights the possibility of using the thermo-expandable Memokath
tent 045 as an alternative to the long-term management of ileal
onduit stomal stenosis.onﬂict of interest
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